146294-95-3Relevant articles and documents
HETEROCYCLIC COMPOUND
-
Paragraph 0416; 0417, (2015/05/26)
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the f
SYNTHESES OF FUNCTIONALIZED N-(2-PYRIDYL)-α-AMINO ACIDS AND ESTERS BY RING OPENING OF IMIDAZOPYRIDINE
Doise, Muriel,Blondeau, Dominique,Sliwa, Henri
, p. 2079 - 2093 (2007/10/02)
This report is devoted to the ring opening of the imidazole nucleus of functionalized imidazopyridines, by methanol in strong acid medium (HClO4) leading to esters of N-(2-pyridyl)-α-amino acids in which the heterocyclic moiety bears a functional g